Triple-negative breast cancer: Prolactin study may lead to new treatments

[News]

Study suggests a prolactin receptor screen could identify triple-negative breast cancer patients with a less aggressive cancer and a better prognosis.

More... (http://www.medicalnewstoday.com/articles/313685.php)